abstract |
The present invention discloses a compound of formula I wherein R 1 , R 2a , R 2b , R 2c , R 3 , Y and p are as defined herein and C2-C3 are single or double bonds, which is polymerized by hepatitis C virus NS5b Enzyme inhibitors. The invention also discloses compositions and methods for treating HCV infection and inhibiting HCV replication. |